As many as 32 patients have died of mucormycosis in the last 20 days at a government-run hospital in Madhya Pradesh's Indore city, an official said on Wednesday.

****!!!!**** "The treatment of mucormycosis and other fungal infection is provided free of cost in all Central Government hospitals and autonomous institutions under the ministry, he said in a separate reply. Ayushman Bharat PM-JAY provides free health cover up to Rs. 5 lakh per year per family. The scheme was launched with 10.74 crore beneficiary families. However, 33 states/UTs have increased the beneficiary base to 13.44 families. Beneficiaries of Ayushman Bharat PM-JAY can avail free treatment of post-Covid related complications including Mucormycosis, Black Fungus etc. under the scheme. States are also being supported in terms of allocation and supply of Amphotericin B. Amphotericin B is being provided at an affordable price under the Pradhan Mantri Bhartiya Janaushadhi Pariyojna (PMBJP)."

Information on risk of fungal diseases in patients with severe COVID-19; information about fungal co-infection with COVID-19.

2020 "COVID-19 patients, especially severely ill or immunocompromised, have a higher probability of suffering from invasive mycoses. Aspergillus and Candida infections in COVID-19 patients will require early detection by a comprehensive diagnostic intervention (histopathology, direct microscopic examination, culture, (1,3)-β-d-glucan, galactomannan, and PCR-based assays) to ensure effective treatments. We suggest it is prudent to assess the risk factors, the types of invasive mycosis, the strengths and limitations of diagnostic methods, clinical settings, and the need for standard or individualized treatment in COVID-19 patients. We provide a clinical flow diagram to assist the clinicians and laboratory experts in the management of aspergillosis, candidiasis, mucormycosis, or cryptococcosis as co-morbidities in COVID-19 patients."